Pushkal Garg
EVP Chief R&D · ALNYLAM PHARMACEUTICALS, INC.
- 2024
- Mar 6, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pushkal Garg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yvonne Greenstreet - $16.95M in ALNY purchases and sales in the last 12 months
- Kevin Joseph Fitzgerald - $8.24M in ALNY purchases and sales in the last 12 months
- Jeffrey V. Poulton - $2.22M in ALNY purchases and sales in the last 12 months
- Tolga Tanguler - $1.88M in ALNY purchases and sales in the last 12 months
- Melissa McLaughlin - $1.27M in ALNY purchases and sales in the last 12 months
- David E. I. Pyott - $1.15M in ALNY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pushkal Garg?
Pushkal Garg is a corporate insider, tracked as EVP Chief R&D of ALNYLAM PHARMACEUTICALS, INC. (ALNY). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Pushkal Garg last file a Form 4?
The most recent primary Form 4 on record is dated 6 March 2026, one of 9 filings going back to 2024.
Has Pushkal Garg been buying or selling stock?
Recorded transactions: 0 open-market purchases and 75 open-market sales ($9.74M) across all tracked filings.
